Ligand Development

Publications

  • Treudler R, Delaroque N, Puder M, Simon JC, Szardenings M. Dupilumab-induced serum sickness-like reaction: an unusual adverse effect in a patient with atopic eczema. J Eur Acad Dermatol Venereol. 2020 Jun 27. dx.doi.org/10.1111/jdv.16782. Online ahead of print
  • Kern K, Havenith H, Delaroque N, Rautenberger P, Lehmann J, Fischer M, Spiegel H, Schillberg S, Ehrentreich-Foerster E, Aurich S, Treudler R, Szardenings M. The immunome of soy bean allergy: Comprehensive identification and characterization of epitopes. Clin Exp Allergy. 2019 Feb;49(2):239-251. dx.doi.org/10.1111/cea.13285. Epub 2018 Dec 3
  • Ahn J-S, Kim H-J, Kim YK, Lee S-S, Ahn SY, Jung SH, Yang DH, Lee JJ, Park HJ, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Szardenings M, Minden M, Hwan K, Dennis D. 5-Hydro-xymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. OncoTarget. 8 (2017), 5, S. 8305-8314. dx.doi.org/10.18632/oncotarget.14171
  • Havenith H, Kern K, Rautenberger P, Spiegel H, Szardenings M, Ueberham E, Lehmann J, Buntru M, Vogel S, Treudler R, Fischer R, Schillberg S. Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants. Biotechnol J. 2017 Feb;12(2). dx.doi.org/10.1002/biot.201600441
  • Kim T, Tyndel MS, Zhang Z, Ahn J, Choi S, Szardenings M, Lipton JH, Kim HJ, Kim Dong Hwan D. Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy. Leuk Res. 2017 Aug;59:142-148. dx.doi.org/10.1016/j.leukres.2017.06.009. Epub 2017 Jun 16
  • Kunath J, Delaroque N, Szardenings M, Neundorf I, Straub RH. Sympathetic nerve repulsion inhibited by designer molecules in vitro and role in experimental arthritis. Life Sci. 2017 Jan 1;168:47-53. dx.doi.org/10.1016/j.lfs.2016.11.009. Epub 2016 Nov 14
  • Corrales Ureña YR, Lisboa-Filho PN, Szardenings M, Gätjen L, Noeske, P LM, Rischka K. Formation and composition of adsorbates on hydrophobic carbon surfaces from aqueous laccase-maltodextrin mixture suspension. Applied surface science. 385 (2016), S. 216-224. dx.doi.org/10.1016/j.apsusc.2016.05.097
  • Kang MG, Choi HW, Lee JH, Choi YJ, Choi HJ, Shin JH, Suh SP, Szardenings M, Kim HR, Shin MG. Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia. Oncotarget. 2016 Aug 30;7(35):57036-57049. dx.doi.org/10.18632/oncotarget.10958
  • Kang MG, Kim YN, Lee JH, Szardenings M, Baek HJ, Kook H, Kim HR, Shin MG. Clinicopathological Implications of Mitochondrial Genome Alterations in Pediatric Acute Myeloid Leukemia. Ann Lab Med. 2016 Mar;36(2):101-10. dx.doi.org/10.3343/alm.2016.36.2.101
  • Park SH, Zheng JH, Nguyen VH, Jiang SN, Kim DY, Szardenings M, Min JH, Hong Y, Choy HE, Min JJ. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016 Jun 20;6(10):1672-82. dx.doi.org/10.7150/thno.16135. eCollection 2016
  • Kim HR, Won SJ, Fabian C, Kang MG, Szardenings M, Shin MG. Mitochondrial DNA aberrations and pathophysiological implications in hematopoietic diseases, chronic inflammatory diseases, and cancers. Ann Lab Med. 2015 Jan;35(1):1-14. dx.doi.org/10.3343/alm.2015.35.1.1. Epub 2014 Dec 8
  • Kim JE, Phan TX, Nguyen VH, Dinh-Vu HV, Zheng JH, Yun M, Park SG, Hong Y, Choy HE, Szardenings M, Hwang W, Park JA, Park S, Im SH, Min JJ. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015 Oct 6;5(12):1328-42. dx.doi.org/10.7150/thno.11432. eCollection 2015
  • Won EJ, Kim HR, Park RY, Choi SY, Shin JH, Suh SP, Ryang DW, Szardenings M, Shin MG. Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications. BMC Cancer. 2015 Apr 2;15:217. dx.doi.org/10.1186/s12885-015-1233-x
  • Jiang SN, Park SH, Lee HJ, Zheng JH, Kim HS, Bom HS, Hong Y, Szardenings M, Shin MG, Kim SC, Ntziachristos V, Choy HE, Min JJ. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. Mol Ther. 2013 Nov;21(11):1985-95. dx.doi.org/10.1038/mt.2013.183. Epub 2013 Aug 7